A Study of KB408 for the Treatment of Alpha-1 Antitrypsin Deficiency
A Study of KB408 for the Treatment of Alpha-1 Antitrypsin Deficiency
Recruiting · NCT06049082 · Registry updated 2025-07-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of KB408 for the Treatment of Alpha-1 Antitrypsin Deficiency | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Subcutaneous Emphysema, alpha 1-antitrypsin deficiency, hereditary disease, liver disorder, lung disorder, pulmonary emphysema, respiratory system disorder | Recruiting | Phase 1 | 2025-07-22 | NCT06049082 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Krystal Biotech, Inc. | 11 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Medical University of South Carolina | Charleston | United States | 628 |
| Renovatio Clinical | The Woodlands | United States | 20 |
| University of Florida, Gainesville | Gainesville | United States | 4 |